Health Catalyst, Inc. (HCAT) Profit Margin
Health Catalyst, Inc. (HCAT) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | -38.79% |
| 2020-12-31 | -60.91% |
| 2021-12-31 | -63.33% |
| 2022-12-31 | -49.74% |
| 2023-12-31 | -39.92% |
| 2024-12-31 | -22.67% |
| 2025-12-31 | -57.20% |
How HCAT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| PRGO | Perrigo Company plc | -33.51% |
| NMTC | NeuroOne Medical Technologies Corporation | -39.63% |
| OSUR | OraSure Technologies Inc. | -59.76% |
| QTRX | Quanterix Corporation | -77.14% |
| RARE | Ultragenyx Pharmaceutical Inc. | -85.44% |
These are five companies in the same sector as HCAT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Health Catalyst, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("HCAT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HCAT | $1.77 | -4.05% | 0.29M |
| 3 | ||||
| 4 | ||||
| 5 |